Polares Medical (Group)

Polares Medical SA, a preclinical stage medical technology company focused on the development of a unique trans-catheter mitral valve hemi-replacement system to treat patients suffering from mitral regurgitation (MR), in July 2018 announced the closing of a $25 million financing led by Decheng Capital (Menlo Park and Shanghai) together with Endeavour Vision (Geneva), IDO Investments (Muscat), Earlybird Venture Capital (Berlin) and Wellington Partners (Munich). Polares Medical’s solution to MR is based on the original concept of hemi-replacement of the mitral valve, i.e. the replacement of the posterior leaflet with a prosthetic leaflet designed to enhance coaptation with the native anterior leaflet. Polares Medical was created as a spin-off of Symetis SA to develop the mitral technology that Symetis obtained through its acquisition of Middle Peak Medical GmbH, prior to Boston Scientific Corporation’s acquisition of Symetis in 2017. *

	Start	2017-01-01 established (s-off)
	Predecessor	Middle Peak Medical (Group)
	Industry	valve (medical)
	Person	Essinger, Jacques R. (Symetis 201703 CEO)

	Region	Ecublens VD
	Country	Switzerland
	City	n. a.
		Address record changed: 2018-07-18

Basic data	Employees	n. a.

		* Document for »About Section«: Polares Medical S.A.. (7/17/18). "Press Release: Polares Medical Closes a $25m Financing to Enter Clinical Validation". Lausanne & Palo Alto, CA.

		Record changed: 2019-08-09

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for Polares Medical (Group)

[1] Polares Medical S.A.. (7/17/18). "Press Release: Polares Medical Closes a $25m Financing to Enter Clinical Validation". Lausanne & Palo Alto, CA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]